Filippo Passerini has sold his shares in Integer Holdings Corp as part of a merger agreement, a move that marks a notable change in his ownership status. This transaction occurred on November 17, 2026, and reflects the ongoing consolidation within the electromedical and electrotherapeutic apparatus industry.
The merger agreement, dated August 2, 2026, involves Integer Holdings Corp, Armstrong Parent, Inc., and Armstrong Bidco, Inc. As per the agreement, Passerini's shares were converted into the right to receive $127 in cash for each share disposed of. Additionally, his departure from the board of directors at the effective time of the merger resulted in the cancellation of his restricted stock units, which were also converted into cash equivalent to the merger consideration.
Integer Holdings Corp, known for its focus on electromedical and electrotherapeutic apparatus, is navigating a competitive landscape as it seeks to enhance its market position through strategic mergers and acquisitions. The implications of Passerini's departure and the merger could influence the company’s future direction and its standing among competitors in the industry.
Details regarding future actions or filings related to this merger were not specified in the SEC filing.
Transaction Details
In the transaction reported, Filippo Passerini disposed of a total of 31,114 shares of common stock in Integer Holdings Corp. This transaction was executed under the code 'D', indicating a disposal of shares as part of the merger agreement. Following this transaction, Passerini no longer holds any shares in the company, as his post-transaction ownership is recorded as zero shares.
Company Background
Integer Holdings Corp, incorporated in Delaware, operates within the electromedical and electrotherapeutic apparatus sector, classified under the Standard Industrial Classification of 3845. The company has undergone several name changes, previously known as Greatbatch, Inc. and Wilson Greatbatch Technologies Inc., reflecting its evolving business strategy and focus in the medical device industry.
Legal and Compliance Information
The filing is submitted under the SEC Act of 1934, and it is categorized as a Form 4, which is typically used to report changes in ownership by company insiders. The filing was made on November 19, 2026, following the transaction date of November 17, 2026, ensuring compliance with SEC regulations regarding timely disclosure of insider transactions.
"Each share of common stock of the issuer, par value $0.001 per share, held by the reporting person was converted into the right to receive $127 in cash, without interest."
While the filing provides comprehensive details about the transaction and Passerini's departure from the board, it does not include information about his future plans or any potential new roles he may pursue following this significant change in his professional engagement.
Read Next
Lucidi Bruno Reports Stock Transactions in Atea Pharmaceuticals
Grove Collaborative director Jason Karp increases stock holdings
Suncrete, Inc. Director Andrew Heyer Acquires 25,000 Shares
Tackett Ross Justyn Discloses Share Ownership in Zscaler
Manchester Management PR, LLC Increases Stake in Modular Medical
CervoMed CEO John Alam Acquires Over 99,000 Shares





